| Product Code: ETC7658442 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Israel`s import shipments of Paracetamol IV in 2024 were mainly sourced from Switzerland, UK, Belgium, USA, and Germany. The market showed low concentration with a Herfindahl-Hirschman Index (HHI) remaining very low. The compound annual growth rate (CAGR) from 2020 to 2024 was -2.14%, indicating a slight decline in the market. Furthermore, the growth rate from 2023 to 2024 was -0.41%, reflecting a marginal decrease in import volumes. This data suggests a stable yet slightly declining trend in the Paracetamol IV import market in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Paracetamol IV Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Paracetamol IV Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Paracetamol IV Market - Industry Life Cycle |
3.4 Israel Paracetamol IV Market - Porter's Five Forces |
3.5 Israel Paracetamol IV Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Israel Paracetamol IV Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Paracetamol IV Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Israel Paracetamol IV Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of diseases and conditions necessitating intravenous administration of paracetamol |
4.2.2 Increasing focus on pain management and palliative care in healthcare settings |
4.2.3 Technological advancements in drug delivery systems for intravenous medications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and marketing of intravenous medications |
4.3.2 Competition from alternative pain management therapies and medications |
4.3.3 Concerns regarding potential adverse effects and misuse of intravenous paracetamol |
5 Israel Paracetamol IV Market Trends |
6 Israel Paracetamol IV Market, By Types |
6.1 Israel Paracetamol IV Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Israel Paracetamol IV Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Israel Paracetamol IV Market Revenues & Volume, By Pain, 2021- 2031F |
6.1.4 Israel Paracetamol IV Market Revenues & Volume, By Pyrexia (Fever), 2021- 2031F |
6.2 Israel Paracetamol IV Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Paracetamol IV Market Revenues & Volume, By Surgical, 2021- 2031F |
6.2.3 Israel Paracetamol IV Market Revenues & Volume, By Non-surgical, 2021- 2031F |
6.3 Israel Paracetamol IV Market, By End-use |
6.3.1 Overview and Analysis |
6.3.2 Israel Paracetamol IV Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Israel Paracetamol IV Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Israel Paracetamol IV Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Paracetamol IV Market Import-Export Trade Statistics |
7.1 Israel Paracetamol IV Market Export to Major Countries |
7.2 Israel Paracetamol IV Market Imports from Major Countries |
8 Israel Paracetamol IV Market Key Performance Indicators |
8.1 Number of hospitals and healthcare facilities adopting intravenous paracetamol for pain management |
8.2 Patient satisfaction rates with the effectiveness of intravenous paracetamol in pain relief |
8.3 Frequency of adverse events reported related to the use of intravenous paracetamol |
9 Israel Paracetamol IV Market - Opportunity Assessment |
9.1 Israel Paracetamol IV Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Israel Paracetamol IV Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Paracetamol IV Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Israel Paracetamol IV Market - Competitive Landscape |
10.1 Israel Paracetamol IV Market Revenue Share, By Companies, 2024 |
10.2 Israel Paracetamol IV Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here